13.08
price up icon1.79%   0.23
after-market アフターアワーズ: 12.52 -0.56 -4.28%
loading
前日終値:
$12.85
開ける:
$12.85
24時間の取引高:
4.94M
Relative Volume:
3.05
時価総額:
$1.12B
収益:
$139.71M
当期純損益:
$-209.36M
株価収益率:
-5.0698
EPS:
-2.58
ネットキャッシュフロー:
$-160.60M
1週間 パフォーマンス:
-6.10%
1か月 パフォーマンス:
-17.99%
6か月 パフォーマンス:
-32.12%
1年 パフォーマンス:
-33.60%
1日の値動き範囲:
Value
$12.75
$13.15
1週間の範囲:
Value
$12.75
$14.18
52週間の値動き範囲:
Value
$12.75
$25.34

Syndax Pharmaceuticals Inc Stock (SNDX) Company Profile

Name
名前
Syndax Pharmaceuticals Inc
Name
セクター
Healthcare (1176)
Name
電話
781-419-1400
Name
住所
35 GATEHOUSE DRIVE, WALTHAM, MA
Name
職員
184
Name
Twitter
@syndax
Name
次回の収益日
2024-11-05
Name
最新のSEC提出書
Name
SNDX's Discussions on Twitter

SNDX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
SNDX
Syndax Pharmaceuticals Inc
13.08 1.12B 139.71M -209.36M -160.60M -2.96
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
397.27 102.31B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
701.85 77.13B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
623.82 37.30B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
245.44 31.66B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
113.08 27.11B 3.30B -501.07M 1.03B -2.1146

Syndax Pharmaceuticals Inc Stock (SNDX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-10-24 開始されました UBS Buy
2024-06-28 開始されました Jefferies Buy
2024-01-31 ダウングレード Scotiabank Sector Outperform → Sector Perform
2023-12-22 開始されました Mizuho Buy
2023-10-25 開始されました BofA Securities Buy
2023-10-11 開始されました Goldman Buy
2023-07-27 開始されました Scotiabank Sector Outperform
2023-07-11 開始されました Guggenheim Buy
2023-04-17 再開されました BTIG Research Buy
2023-01-31 開始されました Stifel Buy
2023-01-03 開始されました JP Morgan Overweight
2022-07-28 再開されました B. Riley Securities Buy
2022-04-11 開始されました H.C. Wainwright Buy
2022-02-15 開始されました Goldman Buy
2021-06-04 再開されました Robert W. Baird Outperform
2021-05-25 開始されました Citigroup Buy
2021-02-18 開始されました B. Riley Securities Buy
2020-12-03 開始されました Stifel Buy
2020-05-22 アップグレード Citigroup Neutral → Buy
2020-05-22 ダウングレード H.C. Wainwright Buy → Neutral
2020-05-18 ダウングレード Citigroup Buy → Neutral
2020-05-11 繰り返されました H.C. Wainwright Buy
2020-03-04 開始されました Barclays Overweight
2020-01-13 繰り返されました H.C. Wainwright Buy
2019-03-08 繰り返されました H.C. Wainwright Buy
2019-01-04 開始されました Robert W. Baird Outperform
2018-01-05 開始されました B. Riley FBR, Inc. Buy
2017-03-16 開始されました FBR & Co. Outperform
2017-03-02 開始されました Instinet Buy
2016-10-07 開始されました Guggenheim Buy
2016-03-28 開始されました Citigroup Buy
2016-03-28 開始されました JMP Securities Mkt Outperform
2016-03-28 開始されました Morgan Stanley Overweight
すべてを表示

Syndax Pharmaceuticals Inc (SNDX) 最新ニュース

pulisher
Dec 19, 2024

Syndax Pharmaceuticals' SWOT analysis: stock poised for growth amid FDA approvals - Investing.com

Dec 19, 2024
pulisher
Dec 19, 2024

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) for Potential Breaches of Fiduciary Duty By Its Board of Directors - The Eastern Progress Online

Dec 19, 2024
pulisher
Dec 19, 2024

Franklin Resources Inc. Grows Position in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - MarketBeat

Dec 19, 2024
pulisher
Dec 19, 2024

SNDX stock touches 52-week low at $13.26 amid market challenges - Investing.com Canada

Dec 19, 2024
pulisher
Dec 18, 2024

Syndax Pharmaceuticals (NASDAQ:SNDX) Reaches New 1-Year LowShould You Sell? - MarketBeat

Dec 18, 2024
pulisher
Dec 18, 2024

State Street Corp Has $72.59 Million Holdings in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - MarketBeat

Dec 18, 2024
pulisher
Dec 17, 2024

Fmr LLC Has $948,000 Holdings in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - Defense World

Dec 17, 2024
pulisher
Dec 17, 2024

(SNDX) Technical Pivots with Risk Controls - Stock Traders Daily

Dec 17, 2024
pulisher
Dec 16, 2024

Syndax Pharmaceuticals Announces Additional Positive Data for Revuforj from Augment-101 Trial in Relapsed or Refractory Mnpm1 Aml and Beat Aml Frontline Combination Trial - Marketscreener.com

Dec 16, 2024
pulisher
Dec 15, 2024

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Short Interest Update - MarketBeat

Dec 15, 2024
pulisher
Dec 15, 2024

Syndax Pharmaceuticals (NASDAQ:SNDX) Shares Gap Down – Time to Sell? - Defense World

Dec 15, 2024
pulisher
Dec 15, 2024

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $2.65 Million Stake in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - Defense World

Dec 15, 2024
pulisher
Dec 15, 2024

BNP Paribas Financial Markets Buys 16,663 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - Defense World

Dec 15, 2024
pulisher
Dec 15, 2024

Syndax Pharmaceuticals' SWOT analysis: biotech stock poised for growth amid challenges - Investing.com

Dec 15, 2024
pulisher
Dec 14, 2024

Syndax Pharmaceuticals (NASDAQ:SNDX) Shares Gap DownTime to Sell? - MarketBeat

Dec 14, 2024
pulisher
Dec 13, 2024

The Manufacturers Life Insurance Company Has $918,000 Stock Position in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - Defense World

Dec 13, 2024
pulisher
Dec 13, 2024

Syndax Pharmaceuticals’ (SNDX) “Buy” Rating Reiterated at HC Wainwright - Defense World

Dec 13, 2024
pulisher
Dec 11, 2024

Y Intercept Hong Kong Ltd Buys 61,916 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - MarketBeat

Dec 11, 2024
pulisher
Dec 11, 2024

SNDX stock touches 52-week low at $14.99 amid market shifts By Investing.com - Investing.com South Africa

Dec 11, 2024
pulisher
Dec 10, 2024

SNDX stock touches 52-week low at $14.99 amid market shifts - Investing.com Canada

Dec 10, 2024
pulisher
Dec 10, 2024

SNDXSyndax Pharmaceuticals, Inc. Latest Stock News & Market Updates - StockTitan

Dec 10, 2024
pulisher
Dec 10, 2024

Syndax Pharmaceuticals (NASDAQ:SNDX) Given Buy Rating at HC Wainwright - MarketBeat

Dec 10, 2024
pulisher
Dec 10, 2024

While Syndax Pharmaceuticals (NASDAQ:SNDX) shareholders have made 85% in 5 years, increasing losses might now be front of mind as stock sheds 6.8% this week - Simply Wall St

Dec 10, 2024
pulisher
Dec 10, 2024

Wellington Management Group LLP Cuts Holdings in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - MarketBeat

Dec 10, 2024
pulisher
Dec 10, 2024

Two Sigma Advisers LP Purchases 48,100 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - MarketBeat

Dec 10, 2024
pulisher
Dec 10, 2024

Syndax Pharmaceuticals Announces Additional Positive Data for Revuforj®? from Augment-101 Trial in Relapsed or Refractory Mnpm1 Aml and Beat Aml Frontline Combination Trial - Marketscreener.com

Dec 10, 2024
pulisher
Dec 09, 2024

Syndax's Revuforj Shows Breakthrough 100% Response Rate in AML Clinical Trial Data - StockTitan

Dec 09, 2024
pulisher
Dec 09, 2024

Charles Schwab Investment Management Inc. Grows Holdings in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - MarketBeat

Dec 09, 2024
pulisher
Dec 08, 2024

Quantbot Technologies LP Acquires Shares of 2,542 Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - Defense World

Dec 08, 2024
pulisher
Dec 07, 2024

Syndax's Revuforj Shows Remarkable 82% Response Rate in Leukemia Clinical Trials at ASH Meeting - StockTitan

Dec 07, 2024
pulisher
Dec 07, 2024

Verition Fund Management LLC Has $1.53 Million Holdings in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - MarketBeat

Dec 07, 2024
pulisher
Dec 06, 2024

BlackRock, Inc. Acquires Additional Shares in Syndax Pharmaceuti - GuruFocus.com

Dec 06, 2024
pulisher
Dec 06, 2024

(SNDX) Proactive Strategies - Stock Traders Daily

Dec 06, 2024
pulisher
Dec 05, 2024

Syndax Pharmaceuticals (STU:1T3) Change In Prepaid Assets : €-6.79 Mil (TTM As of Sep. 2024) - GuruFocus.com

Dec 05, 2024
pulisher
Dec 05, 2024

Syndax Pharmaceuticals (STU:1T3) COGS-to-Revenue : 0.00 (As of Sep. 2024) - GuruFocus.com

Dec 05, 2024
pulisher
Dec 05, 2024

Point72 Asset Management L.P. Sells 67,086 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - MarketBeat

Dec 05, 2024
pulisher
Dec 04, 2024

SNDX (Syndax Pharmaceuticals) FCF Margin % : -498.58% (As of Sep. 2024) - GuruFocus.com

Dec 04, 2024
pulisher
Dec 04, 2024

Why Is Syndax Pharmaceuticals, Inc. (SNDX) Among the Best Small-Cap Biotech Stocks With Massive Potential According to Hedge Funds? - Insider Monkey

Dec 04, 2024
pulisher
Dec 04, 2024

Parkman Healthcare Partners LLC Has $9.78 Million Stake in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - MarketBeat

Dec 04, 2024
pulisher
Dec 03, 2024

Syndax Pharmaceuticals Awards Key Talent with Strategic Stock Options Package - StockTitan

Dec 03, 2024
pulisher
Dec 03, 2024

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Receives $37.64 Average PT from Analysts - MarketBeat

Dec 03, 2024
pulisher
Dec 03, 2024

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World

Dec 03, 2024
pulisher
Nov 30, 2024

Eventide Asset Management LLC Buys New Holdings in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - MarketBeat

Nov 30, 2024
pulisher
Nov 28, 2024

Syndax Pharmaceuticals, Inc. announced that it expects to receive funding from Kyowa Hakko Kirin Co., Ltd. - Marketscreener.com

Nov 28, 2024
pulisher
Nov 27, 2024

Syndax Pharmaceuticals, Inc. announced that it expects to receive $30 million in funding from Hercules Capital, Inc. - Marketscreener.com

Nov 27, 2024
pulisher
Nov 27, 2024

Syndax Announces Participation at the Citi 2024 Global Healthcare Conference - StockTitan

Nov 27, 2024
pulisher
Nov 26, 2024

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Shares Purchased by Propel Bio Management LLC - MarketBeat

Nov 26, 2024
pulisher
Nov 26, 2024

Syndax Pharmaceuticals' SWOT analysis: stock outlook brightens on FDA approvals - Investing.com Canada

Nov 26, 2024
pulisher
Nov 25, 2024

Long Term Trading Analysis for (SNDX) - Stock Traders Daily

Nov 25, 2024
pulisher
Nov 25, 2024

Syndax Pharmaceuticals (NASDAQ:SNDX) Given New $38.00 Price Target at JPMorgan Chase & Co. - Defense World

Nov 25, 2024
pulisher
Nov 25, 2024

Syndax Pharmaceuticals (NASDAQ:SNDX) Stock Rating Lowered by StockNews.com - Defense World

Nov 25, 2024

Syndax Pharmaceuticals Inc (SNDX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$17.87
price down icon 2.88%
$68.84
price up icon 2.65%
$39.39
price down icon 0.43%
$359.58
price down icon 0.16%
$176.50
price up icon 1.02%
$113.08
price up icon 1.56%
大文字化:     |  ボリューム (24 時間):